img 614-636-4850
  • Follow us:
Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF


BIOSORTIA CONDUCTS MICRO ALGAL CONSORTIA ASSESSMENTS THROUGHOUT THE U.S.

Dublin, OH (August 21, 2014) - Biosortia's scout technologies make it possible to determine and prioritize the most optimal biomass harvesting sites as a source for new chemistry. Biosortia continues to conduct assessments throughout Ohio, Texas, Florida, Alabama, Kentucky, North Carolina, Michigan and Mississippi.


###


About Biosortia Pharmaceuticals - Biosortia Pharmaceuticals is is a division of Algaeventure Systems (AVS). Biosortia has a proven and unique ability to obtain unculturable aquatic microorganism consortia from the natural environment in unprecedented quantities that allows its research team to perform direct study of vast quantities of new natural products. Biosortia is actively engaging drug research and development organizations to explore the vast opportunity of unculturable microorganisms for potential therapeutic agents, and other novel compounds of value in biotechnology fields.